0001236031-18-000018.txt : 20180503
0001236031-18-000018.hdr.sgml : 20180503
20180503163546
ACCESSION NUMBER: 0001236031-18-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180501
FILED AS OF DATE: 20180503
DATE AS OF CHANGE: 20180503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PRICHEP PATRICIA B
CENTRAL INDEX KEY: 0001236215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 18804392
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-05-01
0
0000725363
CEL SCI CORP
CVM
0001236215
PRICHEP PATRICIA B
0
1
0
0
Senior Vice President
Options
2.45
2018-05-01
4
A
0
42607
0.01
A
2028-04-30
Common Stock
42607
216968
D
Options
2.45
2018-05-01
4
A
0
180000
0.01
A
2028-04-30
Common Stock
180000
396968
D
The options were awarded in recognition of the salary that has been deferred over the last 18 months and not paid in cash. The options awarded are equal to 0.25 option for every dollar deferred.
The stock options vest in three (3) equal annual installments commencing one year after the grant date.
Patricia Prichep
2018-05-03